美容医学市场规模、份额和增长分析：按产品、治疗方法、最终用户和地区分类 - 行业预测，2024-2031

2022年全球美容医学市场规模将为131亿美元，从2023年的144亿美元增长到2031年的356亿美元，预测期内（2024-2031年）复合年增长率为10.1%。

由于提供的产品和服务范围广泛，美容市场正在经历显着成长。这种快速增长的背后是社会对外表的日益重视以及对美容治疗的日益接受。医疗技术的创新为那些对传统整容手术犹豫不决的人们提供了新的选择，并有助于扩大市场。美容医学目前包括合法治疗，如抽脂、隆乳、肉毒桿菌注射、填充剂、雷射换肤和除毛疗程。此外，该市场还包括护肤、化妆品、护髮等美容产品。对外观的关注导致侵入性和微创手术的普及。社群媒体和影响者进一步放大了对美感提升的需求，尤其是在年轻族群中。时尚产业也发挥着重要作用，为那些为了自尊、社会接受或个人卓越而寻求改善外表的个人提供了便利。随着科技的进步和自我护理意识的增强，全球对美容护理和产品的需求不断增加。生活方式的改变，包括肥胖的增加，正在影响老年人口并促进市场成长。这一市场扩张的主要驱动力包括美学意识和需求的提高、许多手术是微创的、减少美容治疗的禁忌以及增加可支配收入，尤其是在新兴市场。这些因素预计将支持美容市场的持续成长。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 技术分析
• 价格分析
• 价值链分析
• 市场生态系统
• Start-Ups分析
• 案例研究分析
• 贸易分析
• 专利分析
• 供应链分析
• 监管环境
• 创新矩阵
• 重点投资分析
• 关键成功因素
• 市场魅力指数
• 竞争程度

美容医学市场：副产品

• 市场概况
• 脸部美容产品
  • 肉毒桿菌毒素
  • 真皮填充剂
  • 微晶换肤产品
  • 化学换肤
• 美容植入
  • 乳房植入
    • 硅胶乳房植入
    • 生理食盐水乳房植入
  • 臀部植入
  • 脸部植入
• 皮肤美容仪器
  • 非手术紧肤装置
  • 雷射皮肤修復仪
  • 微针产品
  • 照光治疗仪
• 体型雕塑仪
  • 非手术减脂装置
  • 脂肪团去除装置
  • 抽脂装置
• 医生开出的化妆品和皮肤美白剂
• 拔毛
  • 雷射除毛仪
  • IPL除毛仪
• 纹身去除装置
• 埋线拉提产品
• 医生处方的睫毛产品
• 雷射指甲治疗仪

美容医学市场：依治疗方法分类

• 市场概况
• 外科手术
  • 隆乳手术
  • 鼻整形术
  • 拉皮/身体提升
  • 其他的
• 非手术治疗
  • 抗老/活肤
  • 纹身/疤痕去除
  • 除毛
  • 脂肪分解
  • 其他的

美容医学市场：依最终用户划分

• 市场概况
• 诊所、医院、医疗设施、水疗中心
• 美容中心
• 居家医疗

美容医学市场规模：按地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 英国
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Lutronic（South Korea）
• Vennus Concept（Canada）
• Evolus Inc.（US）
• Cutera（US）
• Eclipse（Belgium）
• Cynosure（US）
• Merz Pharma（Germany）
• Sisram Medical Ltd（Israel）
• BTL Group of Companies（Switzerland）
• Zimmer Biomet（Poland）
• Fotona（US）
• Abbvie Inc.（US）
• Johnson & Johnson（US）
• Bausch Health Companies Inc.（Canada）
• Cutera（US）
• El.En. SPA（Italy）
• Inmode Ltd.（Israel）
• Fotona（Slovenia）
• Merz Pharma（Germany）
• Venus Concept（Canada）
• Aerolase Corp.（US）
• Sciton（US）
• Bohus Biotech Ab（Sweden）
• Lutronic（South Korea）
• Recosmo（South Korea）
• Sharplight Technologies Inc.（Canada）
• Therapeutics, Inc.（US）
• Medytox（South Korea）
• Polytech Health & Aesthetics Gmbh（Germany）
• Asclepion（Germany）
• Apyx Medical（US）
• Gc Aesthetics（Ireland）
• Laser Llc（Russia）
• Huadong Medicine Co., Ltd.（China）
• Revance Aesthetics（US）

Global Medical Aesthetics Market size was valued at USD 13.1 billion in 2022 and is poised to grow from USD 14.4 billion in 2023 to USD 35.6 billion by 2031, growing at a CAGR of 10.1% in the forecast period (2024-2031).

The aesthetic market is experiencing significant growth due to the broad array of products and services available. This surge is driven by the increasing societal emphasis on physical appearance and the growing acceptance of cosmetic treatments. Medical innovations are offering new options for those who may be hesitant about traditional cosmetic surgeries, thus propelling market expansion. Aesthetic medical procedures now include legally performed treatments such as liposuction, breast augmentation, Botox injections, fillers, laser peels, and hair removal therapies. Additionally, the market encompasses beauty products like skincare, cosmetics, and haircare. The focus on physical appearance has led to a rise in the popularity of invasive and minimally invasive procedures. Social media and influencers have further amplified the demand for aesthetic enhancements, particularly among younger demographics. The fashion industry also plays a significant role by catering to individuals seeking to improve their appearance for self-esteem, social acceptance, or personal excellence. As technology advances and awareness of self-care grows, the global demand for aesthetic treatments and products continues to rise. Lifestyle changes, including increased obesity, are impacting older adults and contributing to market growth. Key drivers of this expansion include heightened awareness and demand for aesthetic beauty, the minimally invasive nature of many procedures, reduced taboos surrounding cosmetic treatments, and rising disposable incomes, particularly in emerging markets. These factors are expected to support the continued growth of the aesthetic market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Medical Aesthetics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Medical Aesthetics Market Segmental Analysis

Global medical aesthetics market is segmented based on the Product, Procedure, End-user, and Region. Based on Product, the market is segmented into Facial Aesthetic Products (Botulinum Toxin, Dermal Fillers, Microdermabrasion Products, Chemicals Peels), Cosmetics Implants (Breast Implants {Silicone Breast Implants, Saline Breast Implants}, Gluteal Implants, Facial Implants), Skin Aesthetic Devices (Nonsurgical Skin Tightening Devices, Laser Skin Resurfacing Devices, Micro Needling Products, Light Therapy Devices), Body Contouring Devices (Nonsurgical Fat Reduction Devices, Cellulite Reduction Devices, Liposuctions Devices), Physician-dispensed Cosmeceuticals and Skin Lighteners, Hair Removal Devices (Laser Hair Removal Devices, IPL Hair Removal Devices), Tattoo Removal Devices, Thread Lift Products, Physician- Dispensed Eyelash Products, and Nail Treatment Laser Devices. Based on Procedure, the market is segmented into Surgical Procedures (Breast Augmentation, Rhinoplasty, Facelift and Body Lift, Others), Non-surgical Procedures (Anti-aging And Skin Rejuvenation, Tattoo and Scar Removal, Hair Removal, Lypolysis, and Others. Based on End-user, the market is segmented into Clinics, Hospitals, and Medicals Spas, Beauty Centers, and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.

Drivers of the Global Medical Aesthetics Market

The cosmetic market is witnessing a significant shift towards proactive aesthetic procedures, with individuals increasingly seeking preventive treatments to maintain their youthful appearance rather than waiting until signs of aging become apparent. This trend reflects a millennial approach to self-care, focusing on maintaining a consistent appearance over time. Additionally, there is a growing emphasis on personalized treatments tailored to individual needs and preferences. This customization enhances the patient experience and fosters a stronger connection between clients and spas. As a result, customers are more likely to return, and offering a range of beauty-positive practices becomes crucial for attracting and retaining clients.

Restraints in the Global Medical Aesthetics Market

The regulatory landscape for equipment, procedures, and techniques aimed at preventing or treating diseases is complex and varies significantly across countries. This complexity creates obstacles for the introduction of innovative products and restricts market access for some providers. Navigating different regulatory regimes is challenging, requiring considerable time, resources, and expertise, which can impact the overall healthcare delivery system when introducing new treatments or devices. Additionally, stringent regulatory policies can pose significant barriers for smaller providers and manufacturers, limiting their ability to compete effectively. Consequently, regulatory instability can hinder technological innovation and delay the availability of advanced therapeutic procedures in various regions.

Market Trends of the Global Medical Aesthetics Market

Nonsurgical facial rejuvenation methods, such as botulinum toxin and hyaluronic acid treatments, are gaining popularity globally, contributing to market growth. Individuals with darker skin types often seek alternative medical procedures to achieve a lighter complexion, a trend particularly evident in countries like India, where darker skin tones are common. This ongoing demand supports the growth of such procedures. Additionally, glutathione, once celebrated in countries like the Philippines as a "magical skin whitening" molecule, has gained significant popularity worldwide. Despite some controversy, glutathione therapy for skin whitening is increasingly offered in aesthetic clinics across India, with many now providing IV-based glutathione treatments.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Start-up Analysis
• Case Study Analysis
• Trade Analysis
• Patent Analysis
• Supply Chain Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Market Attractive Index
• Degree of Competition

Medical Aesthetics Market by Product

• Market Overview
• Facial Aesthetic Products
  • Botulinum Toxin
  • Dermal Fillers
  • Microdermabrasion Products
  • Chemicals Peels
• Cosmetics Implants
  • Breast Implants
    • Silicone Breast Implants
    • Saline Breast Implants
  • Gluteal Implants
  • Facial Implants
• Skin Aesthetic Devices
  • Nonsurgical Skin Tightening Devices
  • Laser Skin Resurfacing Devices
  • Micro Needling Products
  • Light Therapy Devices
• Body Contouring Devices
  • Nonsurgical Fat Reduction Devices
  • Cellulite Reduction Devices
  • Liposuctions Devices
• Physician-dispensed Cosmeceuticals and Skin Lighteners
• Hair Removal Devices
  • Laser Hair Removal Devices
  • IPL Hair Removal Devices
• Tattoo Removal Devices
• Thread Lift Products
• Physician- Dispensed Eyelash Products
• Nail Treatment Laser Devices

Medical Aesthetics Market by Procedure

• Market Overview
• Surgical Procedures
  • Breast Augmentation
  • Rhinoplasty
  • Facelift and Body Lift
  • Others
• Non-surgical Procedures
  • Anti-aging And Skin Rejuvenation
  • Tattoo and Scar Removal
  • Hair Removal
  • Lypolysis
  • Others

Medical Aesthetics Market by End-user

• Market Overview
• Clinics, Hospitals, and Medicals Spas
• Beauty Centers
• Home Care Settings

Medical Aesthetics Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • Italy
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Lutronic (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vennus Concept (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evolus Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cutera (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eclipse (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cynosure (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merz Pharma (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sisram Medical Ltd (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BTL Group of Companies (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fotona (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbvie Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cutera (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• El.En. S.P.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inmode Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fotona (Slovenia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merz Pharma (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Venus Concept (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aerolase Corp. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sciton (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bohus Biotech Ab (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lutronic (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Recosmo (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sharplight Technologies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medytox (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polytech Health & Aesthetics Gmbh (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asclepion (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apyx Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gc Aesthetics (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laser Llc (Russia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huadong Medicine Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revance Aesthetics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments